AI assistant
Sending…
Edwards Lifesciences Corp — Director's Dealing 2021
Jun 16, 2021
30042_dirs_2021-06-15_7c96b622-1adc-4e9d-abdc-f4593db91699.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-06-15
Reporting Person: Szyman Catherine M. (CVP, Critical Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-15 | Common Stock | M | 3410.0000 | $22.2867 | Acquired | 31114.7936 | Direct |
| 2021-06-15 | Common Stock | S | 3410.0000 | $101.1700 | Disposed | 27704.7936 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-15 | Employee Stock Option (Right to Acquire) | $22.2867 | M | 3410.0000 | Disposed | 2022-02-18 | Common Stock (3410.0000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.
More from Edwards Lifesciences Corp
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 8
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 17